🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12572+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12572 recruiting trials

Phase 4RecruitingNCT05522465

Short-course High-dose Prednisone and Dexamethasone in Children With ITP

🏥 Fujian Medical University Union Hospital📍 1 site📅 Started Oct 2022View details ↗
Phase 3RecruitingNCT04965038

Early Reperfusion Therapy With Intravenous Thrombolysis for Recovery of VISION in Acute Central Retinal Artery Occlusion

🏥 University Hospital Tuebingen📍 1 site📅 Started Oct 2022View details ↗
RecruitingNCT06645626

Utilisation of Health Services and Quality of Life in Patients With Atypical Parkinsonian Syndromes

👨‍⚕️ Boyd CP Ghosh, MBBS, Wessex Neurological Centre📍 1 site📅 Started Oct 2022View details ↗
Phase 1RecruitingNCT05533372

MAD Study of IA-14069

🏥 ILAb Co., Ltd.📍 1 site📅 Started Oct 2022View details ↗
Phase 2, PHASE3RecruitingNCT05504265

Perioperative Analgesia Modes in Minimally Invasive Esophagectomy

🏥 Cancer Institute and Hospital, Chinese Academy of Medical Sciences📍 1 site📅 Started Oct 2022View details ↗
NARecruitingNCT05416567

Embolization for Meningioma

👨‍⚕️ Ole Solheim, PhD, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway📍 1 site📅 Started Oct 2022View details ↗
NARecruitingNCT05499091

Functional Study to Indentify Genetic Etiology of Rare Diseases - ORIGIN

👨‍⚕️ Estelle COLIN, MD-PhD, escolin@chu-angers.fr📍 1 site📅 Started Oct 2022View details ↗
Phase 3RecruitingNCT05508789

A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)

👨‍⚕️ Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company📍 141 sites📅 Started Oct 2022View details ↗
EARLY_Phase 1RecruitingNCT05851105

the Safety and Efficacy Evaluation of HGI-002 Injection in Patients With Transfusion-Dependent α-Thalassemia

👨‍⚕️ Chao Liu, PHD, Shenzhen Hemogen📍 1 site📅 Started Oct 2022View details ↗
RecruitingNCT06506214

Characterizing Adherence to Treatment and Satisfaction With Care in Patients With Cutaneous Lupus

👨‍⚕️ Carle PAUL, MD, University Hospital, Toulouse📍 4 sites📅 Started Oct 2022View details ↗
Phase 3RecruitingNCT04268524

Randomised Clinical Trial for New Treatment Modalities for Cutaneous Leishmaniasis Caused by Leishmania Tropica, in Pakistan

👨‍⚕️ Koert Ritmeijer, Medecins Sans Frontieres, Netherlands📍 2 sites📅 Started Oct 2022View details ↗
NARecruitingNCT06472986

Activity-Based Therapy and Transcutaneous Spinal Cord Stimulation After Spinal Cord Injury (ABT-TCSCS)

👨‍⚕️ Sukhvinder Kalsi-Ryan, Toronto Rehabilitation Institute📍 1 site📅 Started Oct 2022View details ↗
Phase 4RecruitingNCT05520892

Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in Children

🏥 Fujian Medical University Union Hospital📍 1 site📅 Started Oct 2022View details ↗
RecruitingNCT06012903

Lower Urinary Tract Symptoms and School Functioning in Children

👨‍⚕️ Ellen Vandamme, MD, University Hospital, Ghent📍 1 site📅 Started Oct 2022View details ↗
Phase 3RecruitingNCT05486468

The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment

🏥 Texas Retina Associates📍 1 site📅 Started Oct 2022View details ↗
Phase 4Enrolling by InvitationNCT05544721

A Study of Paravertebral Block in Thoracic Outlet Syndrome

👨‍⚕️ Houssam Farres, MD, Mayo Clinic📍 1 site📅 Started Oct 2022View details ↗
NARecruitingNCT05878977

Biomarkers in Immunotherapy of Melanoma

🏥 Institute of Oncology Ljubljana📍 1 site📅 Started Oct 2022View details ↗
NARecruitingNCT06397339

Indian Transforming Alzheimer's Care Training (INTACT)

🏥 Washington State University📍 1 site📅 Started Oct 2022View details ↗
NARecruitingNCT05957549

Tracking Early Emergence of Sound Perception Impairments in FXS With Multimodal fNIRS/EEG-Preschool Age

🏥 Children's Hospital Medical Center, Cincinnati📍 1 site📅 Started Oct 2022View details ↗
RecruitingNCT05659901

Rocket Study: A Study to Characterize Biomarkers and Disease Progression in Participants With Pelizaeus-Merzbacher Disease

🏥 Ionis Pharmaceuticals, Inc.📍 8 sites📅 Started Oct 2022View details ↗
← PreviousPage 451 of 629Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →